TCL Archive Funding Opportunities: NIAID seeks New Investigator, Risky Research Proposals March 28, 1997
TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive Genitope Therapy In Phase III Trials For Low-Grade B-Cell Non-Hodgkin’s. October 26, 2001